Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Weizmann Institute of Science, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Weizmann Institute of Science, Medical Devices Deals, 2012 to YTD 2018 9
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Therapix Biosciences Enters into Agreement with Weizmann Institute and Tel Aviv Sourasky 12
Janssen Research & Development Enters into Agreement with DayTwo and the Weizmann Institute of Science 13
Janssen Research & Development Enters into Research Agreement with Weizmann Institute of Science 14
Galmed Pharma Enters into Research Agreement with Yeda Research and Development 15
Sun Pharma Enters into Research Agreement with Weizmann Institute of Science and Health Research Institute of Santiago de Compostela 16
XL-protein Enters into Collaboration Agreement with Yeda Research 17
Rosetta Genomics Enters into Co-Development Agreement with Weizmann Institute of Science 18
Immune Pharma Enters Into Co-Development Agreement With Yeda Research 19
Licensing Agreements 20
Stem Cell Medicine Enters into Licensing Agreement with Ramot at Tel Aviv University and Yeda Research and Development 20
TxCell Exercises Option for Licensing Agreement with Yeda Research and Development 21
Tikcro Technologies Amends Research and Licensing Agreement with Yeda Research and Development 22
Soligenix Enters into Licensing Agreement with New York University and Yeda Research and Development 23
XTL Biopharma Amends Licensing Agreement with Yeda Research for hCDR1 24
miCure Therapeutics Enters into Licensing Agreement with Yeda Research 26
Merck Enters into Licensing Agreement with Weizmann Institute of Science 27
PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 28
Weizmann Institute of Science – Key Competitors 29
Weizmann Institute of Science – Key Employees 30
Weizmann Institute of Science – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Government and Public Interest 32
Sep 12, 2018: A new approach to identifying “signposts” on cancer cells may help immune cells eliminate the disease 32
Jul 25, 2018: Combined Approach Offers Hope to Lung Cancer Patients Who Become Resistant to Drugs 34
May 17, 2017: Rare Genetic Defect May Lead to Cancer Drug 36
Jan 26, 2017: Weizmann Institute of Science: Programmed Proteins Might Help Prevent Malaria 37
Product News 38
Jan 23, 2017: RondinX Expands its Microbiome Computational Platform for Drug Development with a Unified Reference Range of Bacterial Dynamics Based on Database of 1,400 Healthy Individuals 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Key Facts 2
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Weizmann Institute of Science, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Weizmann Institute of Science, Deals By Therapy Area, 2012 to YTD 2018 8
Weizmann Institute of Science, Medical Devices Deals, 2012 to YTD 2018 9
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Therapix Biosciences Enters into Agreement with Weizmann Institute and Tel Aviv Sourasky 12
Janssen Research & Development Enters into Agreement with DayTwo and the Weizmann Institute of Science 13
Janssen Research & Development Enters into Research Agreement with Weizmann Institute of Science 14
Galmed Pharma Enters into Research Agreement with Yeda Research and Development 15
Sun Pharma Enters into Research Agreement with Weizmann Institute of Science and Health Research Institute of Santiago de Compostela 16
XL-protein Enters into Collaboration Agreement with Yeda Research 17
Rosetta Genomics Enters into Co-Development Agreement with Weizmann Institute of Science 18
Immune Pharma Enters Into Co-Development Agreement With Yeda Research 19
Stem Cell Medicine Enters into Licensing Agreement with Ramot at Tel Aviv University and Yeda Research and Development 20
TxCell Exercises Option for Licensing Agreement with Yeda Research and Development 21
Tikcro Technologies Amends Research and Licensing Agreement with Yeda Research and Development 22
Soligenix Enters into Licensing Agreement with New York University and Yeda Research and Development 23
XTL Biopharma Amends Licensing Agreement with Yeda Research for hCDR1 24
miCure Therapeutics Enters into Licensing Agreement with Yeda Research 26
Merck Enters into Licensing Agreement with Weizmann Institute of Science 27
PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 28
Weizmann Institute of Science, Key Competitors 29
Weizmann Institute of Science, Key Employees 30
Weizmann Institute of Science, Subsidiaries 31
List of Figures
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Weizmann Institute of Science, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Weizmann Institute of Science, Medical Devices Deals, 2012 to YTD 2018 9